Jean-Philippe Durand

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

Olivier Mir, Romain Coriat, Benoı̂t Blanchet et al. · PLoS ONE · 2012 · 298 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial

Jean-Philippe Durand, G. Deplanque, Vincent Montheil et al. · Annals of Oncology · 2011 · 211 citations · Full text

Medicine, Oncology, Pharmacology +13

Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study

Pascaline Boudou‐Rouquette, Céline Narjoz, Jean Louis Golmard et al. · PLoS ONE · 2012 · 99 citations · Full text

Medicine, Oncology, Pharmacology +16

Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy ,

Clara Vazeille, Anne Jouinot, Jean-Philippe Durand et al. · American Journal of Clinical Nutrition · 2017 · 98 citations

Medicine, Oncology, Chemotherapy +9

An Observational Study of Bevacizumab-Induced Hypertension as a Clinical Biomarker of Antitumor Activity

Olivier Mir, Romain Coriat, Laure Cabanes et al. · The Oncologist · 2011 · 83 citations · Full text

Medicine, Oncology, Pharmacology +17